MedPath

Oral beclomethasone dipropionate treatment for gastrointestinal acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantatio

Not Applicable
Conditions
Patients with symptoms of acute gastrointestinal GVHD after allo-HSCT
Registration Number
JPRN-UMIN000027026
Lead Sponsor
Tokyo Women's Medical University, Department of Hematology
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
5
Inclusion Criteria

Not provided

Exclusion Criteria

1. Cases who can not be collected data. 2. Patients whose research managers judged inappropriate as subjects. 3. Patients who had requested refusal to investigate.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Whether beclomethasone improve GI GVHD grade or reduce the need for systemic glucocorticoid treatment, at two weeks after administration.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath